Adalimumab maintenance therapy for Crohn's disease with intolerance or lost response to infliximab: an open-label study.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/5CA06C01.svg?ark=w1%2F20260515%2F5CA06C01&value=id)](https://nobleid.org/work/w1/20260515/5CA06C01)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors